—Justine Dell’Aringa, associate scientist, Amgen
—Ben Dutzar, scientist, Alder Biopharmaceuticals
—Eric Eith, technical operations, ZymoGenetics
—Paul Engelbrecht, quality control supervisor, Dendreon
—Andrew Feldhaus, scientist, ZymoGenetics
—Lindsay Felker, analytical biochemist, CMC-Icos
—Heather Franklin, senior vice president of business development, ZymoGenetics
—Victor Fung, executive director at Amgen in Seattle, manufacturing expert
—Deborah Garrard, senior project manager, Seattle Genetics
—Alison Grady, quality assurance associate, Seattle Genetics
—Simon Grainger, Seattle account manager, VWR International
—Kari Hale, associate scientist, Amgen
—Paul Hara, senior director of program management, MDS Pharma Services
—Pierrot Harvie, scientist, MDRNA
—Vaughn Himes, executive vice president, technical operations, Seattle Genetics
—Damon Jacobson, clinical research associate, Seattle Children’s Hospital
—James Johnson, chief financial officer, ZymoGenetics
—Lori A. Jones, cellular immunologist, Seattle Cancer Care Alliance
—Eric Keeler, sales and business development, EMD Chemicals
—Edward Kelly, assistant professor, University of Washington
—Chris Kuehn, senior research associate, Trubion Pharmaceuticals
—Dan LaFoe, head of manufacturing, Catch, Inc.
—Dara Lockert, owner, Lockert Project Solutions
—Kurt Lustig, scientist at VLST
—Carmel Lynch, scientist at Seattle Genetics
—Linda MacDonald (formerly Rogers), scientist, NanoString Technologies
—Brad Miller, quality control supervisor, Bio-Rad Laboratories
—Christine Moore, quality assurance associate, Seattle Cancer Care Alliance
—Keith Munson, senior CMC project manager at CMC ICOS Biologics
—Peter Olagunju, compliance manager, ZymoGenetics
—Jason Orthel, pharmacist, Seattle Children’s Hospital
—Bob Overell, president of PhaseRx
—Ralph Paul, Cerep
—Aaron Posey, scientist at VLST
—Pauline Quigley, program manager, University of Washington Center for Systems and Translational Research on Infectious Disease (STRIDE) [Added: 10 am, 3/24/10]
—Tina Quinton, patent attorney, Christensen O’Connor Johnson Kindness
—Tom Reynolds, chief medical officer, Seattle Genetics
—Aimee Roy, quality assurance supervisor, Dendreon
—Tsering Sangmo, senior lab technologist
—David Schubert, president of Accelerator
—Todd Simpson, chief financial officer, Seattle Genetics
—Stephanie Seiler, founder of Gemini BioProjects, contract communications
—Chuck Smith, senior director of quality, Seattle Genetics
—Tony Stepan, field applications specialist, Promega
—Ryan Takeya, biotech manufacturing consultant
—Joe Weil, senior scientist, Trubion Pharmceuticals
—Perry Wilkins, account manager for Invitrogen
—Linda Wilson, scientist, Amgen
—Eden Zasloff, clinical site manager, PrexEra/Quintiles
—Leah Zielinski Yount, quality assurance at Seattle Biomedical Research Institute
